Stock quote - News

Advanced Oncotherapy
AVO: 38.50 0.00 ( 0.00 %) delayed: 16:57PM


  • Advanced Oncotherapy hails completion of key London operations site
    Monday 22 Jul 2019 09:33

    Cancer treatment system developer Advanced Oncotherapy said work had been completed at a London site that would house the first commercial installation of its proton-based radiotherapy system. The £10m refurbishment project would now move into the fit-out phase. Advanced Oncotherapy said the...
    Read more

  • Advanced Oncotherapy announces 'positive' results from proton accelerators comparison study
    Monday 03 Jun 2019 07:56

    Proton therapy system developer Advanced Oncotherapy announced 'positive' results from its comparative study, further demonstrating the competitive advantages of its proprietary proton accelerator. The purpose of the study was to compare the efficiency of both types of proton accelerators....
    Read more

  • Advanced Oncotherapy appoints Moataz Karmalawy as chief commercial officer
    Tuesday 16 Apr 2019 09:15

    Advanced Oncotherapy appointed Moataz Karmalawy as chief commercial officer and president of the US division with immediate effect. Previously Mr Karmalawy served as general manager of the Worldwide Particle Therapy business for Varian Medical Systems, the world's largest manufacturer of...
    Read more

  • Advanced Oncotherapy cancer treatment device receives ISO certification
    Monday 21 Jan 2019 13:33

    Advanced Oncotherapy said its proton therapy system for cancer treatment had obtained ISO certification. The certification was awarded following an audit by independent compliance group Lloyd's Register. 'This certification represents an important milestone for the company,' Advanced...
    Read more

  • Advanced Oncotherapy to raise £10m through placing of shares
    Friday 21 Dec 2018 09:14

    Proton therapy system developer Advanced Oncotherapy said Friday it planned to raise £10m through the placement of shares. The company intended to issue 25,000,000 new ordinary shares at a price of 40p per share raising £10.0m for which it had received firm commitments from new and existing...
    Read more

  • Advanced Oncotherapy losses deepen amid investment in cancer treatment
    Friday 28 Sep 2018 14:44

    Advanced Oncotherapy said its first-half losses deepened as it developed its proton therapy system for cancer treatment. Pre-tax losses for the six months through June amounted to £11.5m, deepening from a loss of £7.9m on-year. The company said its so-called Light system was now generating...
    Read more

  • Advanced Oncotherapy raises £6.4m via a share placement
    Monday 03 Sep 2018 14:02

    Advanced Oncotherapy, a developer of proton therapy systems for cancer treatment, confirmed it had raised £6.4m via a share placement. New shares in the company were issued at 25p each. At 2:02pm: (LON:AVO) Advanced Oncotherapy PLC share price was 0p at 50.5p Story provided by...
    Read more

  • Advanced Oncotherapy losses deepen; remains track to deliver on key milestones
    Wednesday 27 Jun 2018 10:05

    Cancer proton therapy developer Advanced Oncotherapy said Wednesday annual pre-tax losses widened as costs increased. For the year to 31 March, pre-tax losses on ordinary activities deepened to £16.5m from £13.2m the previous year as financing costs soared to £1.99m from £0.11m a year ago....
    Read more

  • Advanced Oncotherapy receives £6.5m payment from Yantai Cipu
    Friday 11 May 2018 09:08

    Advanced Oncotherapy confirmed Friday it had received the first £6.5m instalment from Yantai Cipu, through its affiliated Liquid Harmony, as part of the distribution agreement made in December. The firm also said Liquid Harmony confirmed the balance of £10.0m would be paid in the coming weeks....
    Read more

  • Advanced Oncotherapy agrees assembly, testing site for proton accelerator
    Tuesday 08 May 2018 09:32

    Cancer therapy systems maker Advanced Oncotherapy said Tuesday that it had signed a lease with the UK Government's Science and Technology Facilities Council to establish a UK testing and assembly site for its proton accelerator. The facility would become the testing and assembly site of...
    Read more

  • Advanced Oncotherapy says Yantai Cipu, Chinese pharma distribution company talks continue
    Tuesday 03 Apr 2018 10:05

    Advanced Oncotherapy said Tuesday that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, and a major medical equipment and pharmaceutical distribution company in China are continuing beyond the previously announced date of 31 March 2018. Yantai Cipu informed Advanced...
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Friday 12 Jan 2018 09:00

    Dr Enrico Vanni, Non Executive Director, bought 40,000 shares in the company on the 11th January 2018 at a price of 54.50p. The Director now holds 1,263,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy LIGHT system on track
    Thursday 28 Dec 2017 07:19

    Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, said it remained on schedule with the development of the first LIGHT system. The company said it continued to make significant advancements in the technology development and manufacture of its...
    Read more

  • Advanced Oncotherapy inks distribution deal
    Thursday 07 Dec 2017 09:32

    Advanced Oncotherapy has signed an exclusive distribution agreement to market and sell its LIGHT system across China, Macau, Taiwan, Hong-Kong and South Korea with Yantai CIPU Medical Technology Co. Under the agreement, Yantai CIPU will make a payment of £16.5 million to Advanced Oncotherapy....
    Read more

  • Advanced Oncotherapy operating losses widen
    Friday 29 Sep 2017 07:37

    Advanced Oncotherapy's operating losses rose to £7.3m in the six months to the end of June - up from £5.9m last time. Revenues were nil - unchanged from a year ago - and pre-tax losses increased to £7.8m from £5.9m. Chief executive Nicolas Serandour said: 'Technological development of our LIGHT...
    Read more

  • FLASH: Advanced Oncotherapy operating losses widen
    Friday 29 Sep 2017 07:13

    Story provided by StockMarketWire.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 01 Aug 2017 10:25

    Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 31st July 2017 at a price of 17.75p. The Director now holds 1,223,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy appoints senior VP of medical physics
    Wednesday 14 Jun 2017 08:22

    Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has appointed Dr. Jonathan Farr as senior vice-president of medical physics with immediate effect. Advanced Oncotherapy said Farr would not be taking a board position. Farr is a medical...
    Read more

  • FLASH: Advanced Oncotherapy appoints senior VP of medical physics
    Wednesday 14 Jun 2017 07:10

    Story provided by StockMarketWire.com
    Read more

  • Advanced Oncotherapy update on milestones
    Monday 12 Jun 2017 09:28

    Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has announced further notable progress in the manufacture of its first LIGHT system. Patient positioning system: The group said multiple components of the treatment room had been manufactured,...
    Read more

  • FLASH: Advanced Oncotherapy update on milestones
    Monday 12 Jun 2017 07:09

    Story provided by StockMarketWire.com
    Read more

  • Advanced Oncotherapy draws down £1.3m
    Friday 26 May 2017 07:46

    Advanced Oncotherapy has drawn down the third tranche of £1.3m - less 5%, in accordance with terms for receipt of 95% of nominal value of each tranche - under the financing agreement with Bracknor. Story provided by StockMarketWire.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Monday 15 May 2017 13:30

    Prof Steve Myers, Non Executive Director, bought 400,000 shares in the company on the 15th May 2017 at a price of 26.00p. The Director now holds 450,569 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Thursday 11 May 2017 09:20

    Prof Christopher Nutting, Non Executive Director, bought 202,500 shares in the company on the 9th May 2017 at a price of 24.67p. The Director now holds 217,316 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy draws down £1.3m
    Friday 28 Apr 2017 08:25

    Advanced Oncotherapy a second tranche of £1.3m - less 5%, in accordance with terms for receipt of 95% of nominal value of each tranche - under the £26m financing agreement with Bracknor announced in February. The company said the proceeds would allocated to its projects and for general...
    Read more

  • FLASH: Advanced Oncotherapy draws down £1.3m
    Friday 28 Apr 2017 07:15

    Story provided by StockMarketWire.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Wednesday 26 Apr 2017 17:40

    Dr Mike Sinclair, Chairman, bought 200,000 shares in the company on the 25th April 2017 at a price of 30.44p. The Director now holds 4,928,229 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 25 Apr 2017 09:00

    Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 24th April 2017 at a price of 26.96p. The Director now holds 1,223,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Thursday 13 Apr 2017 09:20

    Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 12th April 2017 at a price of 27.50p. The Director now holds 1,023,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy loan note conversion
    Friday 07 Apr 2017 09:11

    Advanced Oncotherapy has issued 369,307 new ordinary shares following the conversion of loan notes by Bracknor Investment Group. At 9:11am: (LON:AVO) Advanced Oncotherapy PLC share price was 0p at 34p Story provided by StockMarketWire.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 04 Apr 2017 16:20

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 4th April 2017 at a price of 29.25p. The Director now holds 923,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 04 Apr 2017 09:00

    Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 3rd April 2017 at a price of 28.35p. The Director now holds 923,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 04 Apr 2017 09:00

    Dr Mike Sinclair, Chairman, bought 100,000 shares in the company on the 3rd April 2017 at a price of 28.35p. The Director now holds 4,728,229 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Broker Forecast - Beaufort Securities issues a broker note on Advanced Oncotherapy PLC
    Monday 27 Feb 2017 10:30

    Beaufort Securities today downgrades its investment rating on Advanced Oncotherapy PLC (LON:AVO) to hold (from speculative buy). Story provided by StockMarketWire.com
    Read more

  • Advanced Oncotherapy financing deal with Bracknor
    Wednesday 22 Feb 2017 09:59

    Advanced Oncotherapy, the developer of next generation proton therapy systems for cancer treatment, has secured a flexible and staged £26n financing agreement with Bracknor Investment Group, a Dubai-based investment firm. The Agreement gives the company the ability to issue a minimum of £13m in...
    Read more

  • Advanced Oncotherapy strengthens its board
    Thursday 09 Feb 2017 09:48

    Advanced Oncotherapy has appointed Dr Nick Plowman as a non-executive director with immediate effect. Plowman is senior clinical oncologist at St Bartholomew's Hospital and the Hospital for Sick Children at Great Ormond Street in London. Executive chairman Michael Sinclair said: "Dr Plowman...
    Read more

  • Advanced Oncotherapy says Sinophi wants to terminate orders
    Tuesday 24 Jan 2017 11:30

    Proton therapy systems developer Advanced Oncotherapy was informed by Sinophi Healthcare that it wanted to terminate purchase orders announced in March and October 2015. Advanced Oncotherapy said it believes that Sinophi has no legal basis on which to make this termination and will take...
    Read more

  • FTSE mixed ahead of Article 50 ruling as BT dives
    Tuesday 24 Jan 2017 09:02

    London shares are mixed ahead of UK's Supreme Court ruling this morning on royal prerogative and the triggering Article 50 of the Lisbon treaty to begin a countdown to Brexit. Telecoms giant BT (BT.A) was in crisp focus as its shares dumped almost 20% of their value. BT (BT.A) dived 18.6% to...
    Read more

  • Advanced Oncotherapy financing plan talks expanded
    Monday 23 Jan 2017 09:59

    Advanced Oncotherapy has confirmed that the scope of talks with a potential partner on non-dilutive financing has been expanded. Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, announced in September it had started discussions concerning a...
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 03 Jan 2017 14:00

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 3rd January 2017 at a price of 87.00p. The Director now holds 823,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Thursday 22 Dec 2016 17:35

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 22nd December 2016 at a price of 59.75p. The Director now holds 773,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy progress on LIGHT system
    Thursday 22 Dec 2016 07:40

    Advanced Oncotherapy reports further progress in the technical development of the LIGHT system. Advanced Oncotherapy has integrated the proton source and Radio Frequency Quadruple (RFQ), following a successful testing and calibration programme at ADAM, in Geneva. It says this work has...
    Read more

  • FLASH: Advanced Oncotherapy progress on LIGHT system
    Thursday 22 Dec 2016 07:08

    Story provided by StockMarketWire.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Wednesday 21 Dec 2016 12:50

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 21st December 2016 at a price of 56.00p. The Director now holds 748,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Wednesday 21 Dec 2016 09:00

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 20th December 2016 at a price of 55.00p. The Director now holds 723,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 20 Dec 2016 11:40

    Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 19th December 2016 at a price of 50.00p. The Director now holds 698,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Advanced Oncotherapy PLC (AVO)
    Tuesday 29 Nov 2016 12:45

    Dr Enrico Vanni, Non Executive Director, bought 75,000 shares in the company on the 28th November 2016 at a price of 64.70p. The Director now holds 673,946 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Advanced Oncotherapy appoints joint broker
    Tuesday 08 Nov 2016 14:33

    Advanced Oncotherapy has appointed Stifel Nicolaus Europe as joint broker to the company, with immediate effect. Stockdale Securities remains nominated adviser to the company. At 2:33pm: (LON:AVO) Advanced Oncotherapy PLC share price was 0p at 100p Story provided by StockMarketWire.com
    Read more

  • Advanced Oncotherapy issues shares in lieu of fees
    Monday 07 Nov 2016 15:09

    Advanced Oncotherapy has issued 36,946 new ordinary shares to non-executive director Dr Enrico Vanni at 101.5p, the closing mid price on 4 November, in lieu of his fee for the 25 months to September. Vanni now holds 598,946 ordinary shares representing 0.83% of the issued share capital of the...
    Read more

  • Advanced Oncotherap finalises industrialisation deal
    Monday 31 Oct 2016 07:31

    Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has finalised the details of the contract for manufacturing the first LIGHT machine with Thales. This forms part of the partnership with Thales that was announced in February 2016. Thales has...
    Read more

Page 1 |

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.